| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 11/04/2019 | 20h00 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 22/05/2018 | 19h18 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 09/04/2018 | 22h54 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 22/03/2018 | 19h12 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 22/03/2018 | 11h01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 22/03/2018 | 11h01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 22/03/2018 | 11h01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 22/03/2018 | 11h01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 19/03/2018 | 20h17 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 13/03/2018 | 23h16 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 13/03/2018 | 23h12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 13/03/2018 | 23h12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 13/03/2018 | 23h12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 13/03/2018 | 23h11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 13/03/2018 | 23h11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 13/03/2018 | 23h10 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 13/03/2018 | 23h10 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 13/03/2018 | 23h09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 13/03/2018 | 23h09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 13/03/2018 | 23h08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 13/03/2018 | 23h08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 13/03/2018 | 23h08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 13/03/2018 | 23h08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 13/03/2018 | 23h08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 13/03/2018 | 23h08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 13/03/2018 | 23h08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 13/03/2018 | 23h07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 13/03/2018 | 23h04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 13/03/2018 | 23h03 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |
| 13/03/2018 | 23h02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CASC | Cascadian Therapeutics, Inc. (delisted) |